Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP452782.RAD91_-Gx1NRonlCUl0Bpo9uHlZ8QSeUkikpym05l2NrY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP452782.RAD91_-Gx1NRonlCUl0Bpo9uHlZ8QSeUkikpym05l2NrY130_assertion type Assertion NP452782.RAD91_-Gx1NRonlCUl0Bpo9uHlZ8QSeUkikpym05l2NrY130_head.
- NP452782.RAD91_-Gx1NRonlCUl0Bpo9uHlZ8QSeUkikpym05l2NrY130_assertion description "[The clinical manifestation, peripheral blood and bone marrow condition, karyotypes, immunophenotypes, response to treatment, and prognosis of AML evolution from MDS (MDS-AML) were also observed.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452782.RAD91_-Gx1NRonlCUl0Bpo9uHlZ8QSeUkikpym05l2NrY130_provenance.
- NP452782.RAD91_-Gx1NRonlCUl0Bpo9uHlZ8QSeUkikpym05l2NrY130_assertion evidence source_evidence_literature NP452782.RAD91_-Gx1NRonlCUl0Bpo9uHlZ8QSeUkikpym05l2NrY130_provenance.
- NP452782.RAD91_-Gx1NRonlCUl0Bpo9uHlZ8QSeUkikpym05l2NrY130_assertion SIO_000772 15265365 NP452782.RAD91_-Gx1NRonlCUl0Bpo9uHlZ8QSeUkikpym05l2NrY130_provenance.
- NP452782.RAD91_-Gx1NRonlCUl0Bpo9uHlZ8QSeUkikpym05l2NrY130_assertion wasDerivedFrom befree-2016 NP452782.RAD91_-Gx1NRonlCUl0Bpo9uHlZ8QSeUkikpym05l2NrY130_provenance.
- NP452782.RAD91_-Gx1NRonlCUl0Bpo9uHlZ8QSeUkikpym05l2NrY130_assertion wasGeneratedBy ECO_0000203 NP452782.RAD91_-Gx1NRonlCUl0Bpo9uHlZ8QSeUkikpym05l2NrY130_provenance.